Arylsulfonylamino-Benzanilides as Inhibitors of the Apical Sodium-Dependent Bile Salt Transporter (SLC10A2)

The apical sodium-dependent bile salt transporter (ASBT) plays a pivotal role in maintaining bile acid homeostasis. Inhibition of ASBT would reduce bile acid pool size and lower cholesterol levels. In this report, a series of novel arylsulfonylaminobenzanilides were designed and synthesized as poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hong-Tao, He, Hong-Wei, Bai, Xiao-Guang, Wang, Ju-Xian, Xu, Chang-Liang, Cai, Shi-Ying, Shao, Rong-Guang, Wang, Yu-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269792/
https://www.ncbi.nlm.nih.gov/pubmed/23752471
http://dx.doi.org/10.3390/molecules18066883
Descripción
Sumario:The apical sodium-dependent bile salt transporter (ASBT) plays a pivotal role in maintaining bile acid homeostasis. Inhibition of ASBT would reduce bile acid pool size and lower cholesterol levels. In this report, a series of novel arylsulfonylaminobenzanilides were designed and synthesized as potential inhibitors of ASBT. Most of them demonstrated great potency against ASBT’s bile acid transport activity. In particular, compound 5g(2) inhibited ASBT activity with an IC(50) value of 0.11 μM. These compounds represent potential cholesterol-lowering drugs.

Ejemplares similares